Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2015 Nov 1;70(3):e84–e93. doi: 10.1097/QAI.0000000000000783

TABLE 1.

Strategy Descriptions

Strategy Name Description
ALL_H6 2011 policy in Botswana—provide all PLHIV with 6-mo
IPT and initiate ART at CD4 <250 cells/µL
ALL_H36 Provide all PLHIV with 36-mo IPT and initiate ART at
CD4 <250 cells/µL
TST_H6 Provide only TST-positive PLHIV with 6-mo IPT and
initiate ART at CD4 <250 cells/µL
TST_H36 Provide only TST-positive PLHIV with 36-mo IPT and
initiate ART at CD4 <250 cells/µL
TST_H6H36 Provide all PLHIV with 6-mo IPT, extend duration to 36
mo for TST-positives, and initiate ART at CD4 <250
cells/µL
ART_350 Discontinue IPT and increase ART initiation threshold for
PLHIV from CD4 <250 cells/µL to <350 cells/µL
ART_500 Discontinue IPT and increase ART initiation threshold for
PLHIV from CD4 <250 cells/µL to <500 cells/µL